Impaired vascular permeability regulation caused by the VEGF165b splice variant in pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 118, Issue 10, 2011, Pages 1253-1261

  Bills, V L ^a,b   Salmon, A H ^a,c   Harper, S J ^a   Overton, T G ^b   Neal, C R ^a   Jeffery, B ^d   Soothill, P W ^b   Bates, D O ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b ST MICHAEL'S HOSPITAL   (United Kingdom)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

^d UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Hydraulic conductivity; microvascular permeability; pre eclampsia; vascular endothelial growth factor

Indexed keywords

BEVACIZUMAB; MONOCLONAL ANTIBODY; PLACENTAL GROWTH FACTOR; PLACENTAL GROWTH FACTOR 1; SEMAXANIB; UNCLASSIFIED DRUG; VASCULOTROPIN 165; VASCULOTROPIN 165B; VASCULOTROPIN A; VASCULOTROPIN A RECEPTOR; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE REPRESSION; GENETIC VARIABILITY; HUMAN; HYDRAULIC CONDUCTIVITY; HYPOTHESIS; IN VIVO STUDY; INHIBITION KINETICS; MALE; MESENTERIC ARTERY; MICROVASCULATURE; NONHUMAN; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; RNA SPLICING; SIGNAL TRANSDUCTION; SINGLE VESSEL PERFUSION MICROOCCLUSION TECHNIQUE;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOLOGICAL ASSAY; CAPILLARY PERMEABILITY; FEMALE; HUMANS; MEMBRANE PROTEINS; PRE-ECLAMPSIA; PREGNANCY; QUINAZOLINES; RANIDAE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 80051789607     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2011.02925.x     Document Type: Article

References (50)

1. Villar J, Say L, Shennan A, Lindheimer M, Duley L, Conde-Agudelo A, et al., Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre-eclampsia and eclampsia. Int J Gynaecol Obstet 2004; 85 (Suppl 1): S28-41. (Pubitemid 38625916)
2. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA,. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 2002; 9: 147-60. (Pubitemid 135685559)
3. Brockelsby J, Hayman R, Ahmed A, Warren A, Johnson I, Baker P,. VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia. Lab Invest 1999; 79: 1101-11. (Pubitemid 29444540)
4. Knock GA, Poston L,. Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1996; 175: 1668-74. (Pubitemid 27021045)
5. Oian P, Maltau JM, Noddeland H, Fadnes HO,. Transcapillary fluid balance in pre-eclampsia. Br J Obstet Gynaecol 1986; 93: 235-9. (Pubitemid 16111948)
6. Levario-Carrillo M, Avitia M, Tufino-Olivares E, Trevizo E, Corral-Terrazas M, Reza-Lopez S,. Body composition of patients with hypertensive complications during pregnancy. Hypertens Pregnancy 2006; 25: 259-69. (Pubitemid 44655663)
7. Brown MA, Zammit VC, Lowe SA,. Capillary permeability and extracellular fluid volumes in pregnancy-induced hypertension. Clin Sci (Lond) 1989; 77: 599-604. (Pubitemid 20021684)
8. Hays PM, Cruikshank DP, Dunn LJ,. Plasma volume determination in normal and preeclamptic pregnancies. Am J Obstet Gynecol 1985; 151: 958-66. (Pubitemid 15237734)
9. Baker PN, Krasnow J, Roberts JM, Yeo KT,. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 1995; 86: 815-21.
10. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al., Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-58. (Pubitemid 36278583)
11. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al., Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12: 642-9. (Pubitemid 43865232)
12. Spencer K, Cowans NJ, Chefetz I, Tal J, Meiri H,. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol 2007; 29: 128-34. (Pubitemid 46326583)
13. Bates DO, Curry FE,. Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels. Am J Physiol Heart Circ Physiol 1996; 271: H2520-8.
14. Ku DD, Zaleski JK, Liu S, Brock TA,. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 1993; 265: H586-92. (Pubitemid 23273595)
15. Lyall F, Greer IA, Boswell F, Fleming R,. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol 1997; 104: 223-8. (Pubitemid 27065149)
16. McKeeman GC, Ardill JE, Caldwell CM, Hunter AJ, McClure N,. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol 2004; 191: 1240-6. (Pubitemid 39421577)
17. Sharkey AM, Cooper JC, Balmforth JR, McLaren J, Clark DE, Charnock-Jones DS, et al., Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur J Clin Invest 1996; 26: 1182-5.
18. Sankaralingam S, Xu H, Davidge ST,. Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia. Cardiovasc Res 2010; 85: 194-203.
19. Rowe J, Campbell S, Gallery ED,. Plasma from preeclamptic women stimulates decidual endothelial cell growth and prostacyclin but not nitric oxide production: close correlation of prostacyclin and thromboxane production. J Soc Gynecol Investig 2001; 8: 32-8. (Pubitemid 32157080)
20. Takacs P, Green KL, Nikaeo A, Kauma SW,. Increased vascular endothelial cell production of interleukin-6 in severe preeclampsia. Am J Obstet Gynecol 2003; 188: 740-4. (Pubitemid 36332443)
21. Kauma S, Takacs P, Scordalakes C, Walsh S, Green K, Peng T,. Increased endothelial monocyte chemoattractant protein-1 and interleukin-8 in preeclampsia. Obstet Gynecol 2002; 100: 706-14. (Pubitemid 35300027)
22. Haller H, Hempel A, Homuth V, Mandelkow A, Busjahn A, Maasch C, et al., Endothelial-cell permeability and protein kinase C in pre-eclampsia. Lancet 1998; 28: 351.
23. Groten T, Kreienberg R, Fialka I, Huber L, Wedlich D,. Altered subcellular distribution of cadherin-5 in endothelial cells caused by the serum of pre-eclamptic patients. Mol Hum Reprod 2000; 6: 1027-32.
24. Zhang Y, Gu Y, Lewis DF, Wang Y,. Reduced cellular glutathione reductase activity and increased adhesion molecule expression in endothelial cells cultured with maternal plasma from women with preeclampsia. J Soc Gynecol Investig 2006; 13: 412-7. (Pubitemid 46059283)
25. Neal CR, Hunter AJ, Harper SJ, Soothill PW, Bates DO,. Plasma from women with severe pre-eclampsia increases microvascular permeability in an animal model in vivo. Clin Sci (Lond) 2004; 107: 399-405. (Pubitemid 39389307)
26. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW,. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991; 5: 1806-14.
27. Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, Shields JD, et al., VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 2002; 62: 4123-31. (Pubitemid 34791084)
28. Woolard J, Bevan HS, Harper SJ, Bates DO,. Molecular Diversity of VEGF-A as a Regulator of Its Biological Activity. Microcirculation 2009; 10: 1-21.
29. 165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Br J Cancer 2008; 98: 1366-79. (Pubitemid 351543576)
30. Glass CA, Harper SJ, Bates DO,. The anti-angiogenic VEGF isoform VEGF165b transiently increases hydraulic conductivity, probably through VEGF receptor 1 in vivo. J Physiol (Lond) 2006; 572: 243-57.
31. Nelson-Piercy C,. Handbook of Obstetric Medicine, 2nd edn. London: Mauritz Dunitz Ltd, 2010.
32. Michel CC, Mason JC, Curry FE, Tooke JE, Hunter PJ,. A development of the Landis technique for measuring the filtration coefficient of individual capillaries in the frog mesentery. Q J Exp Physiol Cogn Med Sci 1974; 59: 283-309.
33. Landis EM,. Micro-injection studies of capillary permeability. Am J Physiol 1927; 82: 124.
34. Michel CC,. Filtration coefficients and osmotic reflexion coefficients of the walls of single frog mesenteric capillaries. J Physiol (Lond) 1980; 309: 341-55. (Pubitemid 11199944)
35. Starling E,. On the absorbtion of fluids from the connective tissue spaces. J Physiol (Lond) 1896; 19: 312-26.
36. Bates DO, Lodwick D, Williams B,. Vascular endothelial growth factor and microvascular permeability. Microcirculation 1999; 6: 83-96. (Pubitemid 129671107)
37. Harper SJ, Tomson CR, Bates DO,. Human uremic plasma increases microvascular permeability to water and proteins in vivo. Kidney Int 2002; 61: 1416-22. (Pubitemid 34304502)
38. 165b in maternal plasma is a first trimester predictive marker for pre-eclampsia. Clin Sci (Lond) 2009; 116: 265-72.
39. Kim KJ, Li B, Houck K, Winer J, Ferrara N,. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 1992; 7: 53-64.
40. Whittles CE, Pocock TM, Wedge SR, Kendrew J, Hennequin LF, Harper SJ, et al., ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activity. Microcirculation 2002; 9: 513-22. (Pubitemid 135684861)
41. Tille JC, Wang X, Lipson KE, McMahon G, Ferrara N, Zhu Z, et al., Vascular endothelial growth factor (VEGF) receptor-2 signaling mediates VEGF-C(deltaNdeltaC)- and VEGF-A-induced angiogenesis in vitro. Exp Cell Res 2003; 285: 286-98. (Pubitemid 36428960)
42. 165b inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2010; 51: 4282-8.
43. Artac RA, McFee RM, Smith RA, Baltes-Breitwisch MM, Clopton DT, Cupp AS,. Neutralization of vascular endothelial growth factor antiangiogenic isoforms is more effective than treatment with proangiogenic isoforms in stimulating vascular development and follicle progression in the perinatal rat ovary. Biol Reprod 2009; 81: 978-88.
44. Baltes-Breitwisch MM, Artac RA, Bott RC, McFee RM, Kerl JG, Clopton DT, et al., Neutralization of vascular endothelial growth factor antiangiogenic isoforms or administration of proangiogenic isoforms stimulates vascular development in the rat testis. Reproduction 2010; 140: 319-29.
45. 165b. FASEB J 2008; 22: 1104-12. (Pubitemid 351519965)
46. 165b in podocytes reduces glomerular permeability. J Am Soc Nephrol 2010; 21: 1498-509.
47. 165b) are elevated in experimental glaucoma. Mol Vis 2008; 18: 14.
48. Reuvekamp A, Velsing-Aarts FV, Poulina IE, Capello JJ, Duits AJ,. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 1999; 106: 1019-22. (Pubitemid 29457082)
49. Landgren E, Schiller P, Cao Y, Claesson-Welsh L,. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1. Oncogene 1998; 16: 359-67. (Pubitemid 28052290)
50. Hillman NJ, Whittles CE, Pocock TM, Williams B, Bates DO,. Differential effects on Microvascular Hydraulic Conductivity (Lp) of Vascular Endothelial Growth Factor C (VEGF-C) and Placental Growth Factor-1 (PlGF-1). J Vasc Res 2001; 38: 176-85.